Effect of Management Led by the Management Team of Special Disease on Patients with Inflammatory Bowel Disease

doi:10.3969/j.issn.1007-9572.2016.35.022

Abstract

Abstract: Objective　To explore the effect of management led by the management team of special disease on patients with inflammatory bowel disease（IBD）.Methods　131 patients with IBD who received treatment in Department of Spleen and Stomach Disease in Affiliated Hospital of Nanjing University of TCM from March 2014 to February 2015 were selected by convenience sampling method，and were divided into control group（65 cases）and intervention group（66 cases）by random number table method.The patients in control group received routine clinical follow-up of special disease，and patients in intervention group received disease management and follow-up led by special disease management team.Medication compliance，quality of life score，anxiety and depression situation，and symptom severity degree of patients before intervention，intervention the third month and intervention in the sixth month were evaluated by Morisky medication adherence scale（MMAS），IBD questionnaire of quality of life（IBDQ），hospital anxiety and depression scale（HADS）and IBD symptoms and signs rating scale.Results　The main effect of the intervention method and intervention time on MMAS score was significant（P<0.05）；at the third and sixth month of the intervention，the MMAS score of the intervention group was higher than that of the control group（t=6.530，P<0.001；t=3.813，P=0.006）.Intervention method and time had significant effects on the scores of intestinal symptoms，systemic symptoms，social function and IBDQ total score（P<0.05）.The anxiety and depression situation of the intervention group were better than those of the control group at the third and sixth month of the intervention（P<0.05）.Intervention method and time had significant effect on the IBD symptoms and signs rating scale（P<0.05）；at the third and sixth month of the intervention，the IBD symptoms and signs rating scale of intervention group was lower than that of control group（t=2.114，P=0.035；t=2.239，P=0.020）.Conclusion　IBD management，which is led by special disease management team，can effectively improve the medication compliance of patients with IBD，improve the quality of life，reduce the level of anxiety and depression，and improve the disease symptoms.

Key words: Inflammatory bowel disease, Disease management, Medication adherence, Quality of life, Follow-up

摘要： 目的　探讨对炎症性肠病（IBD）患者实施以专病管理团队为主导的疾病管理的效果。方法　采用便利抽样法，选取2014年3月—2015年2月在南京中医药大学附属医院脾胃病科就诊的IBD患者131例，采用随机数字表法将其分为对照组（65例）和干预组（66例），对照组给予常规专病门诊随访和健康教育，干预组实施以专病管理团队为主导的疾病管理和随访。采用Morisky用药依从性量表（MMAS）、IBD患者生活质量问卷（IBDQ）、医院焦虑抑郁量表（HADS）、IBD症状体征分级量化评分表分别评价患者干预前、干预第3个月、干预第6个月时用药依从性、生活质量评分、焦虑抑郁状况以及症状严重程度。结果　干预方法、时间对患者MMAS评分主效应显著（P<0.05）；干预第3、6个月，干预组MMAS评分高于对照组（t=6.530，P<0.001；t=3.813，P=0.006）。干预方法、时间对患者肠道症状、全身症状、社会功能评分以及IBDQ总分主效应显著（P<0.05）。干预第3、6个月时，干预组焦虑、抑郁状况均优于对照组（P<0.05）。干预方法、时间对患者IBD症状体征分级量化评分主效应显著（P<0.05）；干预第3、6个月，干预组IBD症状体征分级量化评分低于对照组（t=2.114，P=0.035；t=2.239，P=0.020）。结论　以专病管理团队为主导的疾病管理能够有效提高IBD患者用药依从性，提高生活质量，降低焦虑、抑郁水平，改善疾病症状。

关键词: 炎症性肠病, 疾病管理, 服药依从性, 生活质量, 随访

CHEN Chen, DAI Xin-juan, LI Jun, XING Jing, SHI Qi, XU Shan-shan. Effect of Management Led by the Management Team of Special Disease on Patients with Inflammatory Bowel Disease[J]. Chinese General Practice, 2016, 19(35): 4397-4402.

陈晨, 戴新娟, 黎军, 邢敬, 施琪, 许珊珊. 以专病管理团队为主导的疾病管理对炎症性肠病患者的效果研究[J]. 中国全科医学, 2016, 19(35): 4397-4402.

References

［1］中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见（2012年·广州）［J］.中华内科杂志，2012，51（10）：818-831. IBD Group of Chinese Society of Gastroenterology.Consensus of diagnosis and theatment of Inflammatory Bowel Disease（2012，Guangzhou）［J］.Chinese Journal of Internal Medicine，2012，51（10）：818-831. ［2］CASELLAS F，VERA I，GINARD D，et al.Inflammatory bowel disease patient’s satisfaction with healthcare services received.Physicians’ and nurses’ perceptions［J］.Rev Esp Enferm Dig，2013，105（7）：385-391. ［3］周凌明，汪春晖，杨国斌，等.综合性医院专病化门诊管理探讨［J］.医学研究生学报，2011，24（10）：1077-1079. ZHOU L M，WANG C H，YANG G B，et al.Probes in disease-specialized outpatient management in comprehensive hospitals［J］.Journal of Medical Postgraduates，2011，24（10）：1077-1079. ［4］陈晨，戴新娟，杨亚，等.疾病管理理论在炎症性肠病患者中的应用进展［J］.护理学杂志，2015，30（17）：109-112. CHEN C，DAI X J，YANG Y，et al.Research progress on disease management theory applied in patient with inflammatory bowel diseases［J］.Journal of Nursing Science，2015，30（17）：109-112. ［5］AGUAS PERIS M，DEL HOYO J，BEBIA P，et al.Telemedicine in inflammatory bowel disease：opportunities and approaches［J］.Inflamm Bowel Dis，2015，21（2）：392-399. ［6］MORISKY D E，ANG A，KROUSEL-WOOD M，et al.Predictive validity of a medication adherence measure in an outpatient setting［J］.J Clin Hypertens（Greenwich），2008，10（5）：348-354. ［7］司在霞，郭灵霞，周敏，等.修订版Morisky服药依从性量表用于抗凝治疗患者的信效度检测［J］.护理学杂志，2012，27（22）：23-26. SI Z X，GUO L X，ZHOU M，et al.Reliability and validity of the modified Morisky Medication Adherence Scale applied to patients on warfarin therapy after mechanical heart-valve replacement［J］.Journal of Nursing Science，2012，27（22）：23-26. ［8］王洁，莫永珍，卞茸文.中文版8条目Morisky用药依从性问卷在2型糖尿病患者中应用的信效度评价［J］.中国糖尿病杂志，2013，21（12）：1101-1104. WANG J，MO Y Z，BIAN R W.Evaluation of reliability and validity of application of the Chinese version of 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes［J］.Chinese Journal of Diabetes，2013，21（12）：1101-1104. ［9］GUYATT G，MITCHELL A，IRVINE E J，et al.A new measure of health status for clinical trials in inflammatory bowel disease［J］.Gastroenterology，1989，96（3）：804-810. ［10］周薇，黎明，李瑜元，等.中文版炎症性肠病问卷的信度和效度研究［J］.国际护理学杂志，2006，25（8）：620-622. ZHOU W，LI M，LI Y Y，et al.The reliability and validity of inflammatory bowel diseases questionnaire in Chinese version［J］.International Journal of Nursing，2006，25（8）：620-622. ［11］张伟，王维利，洪静芳，等.医院焦虑抑郁量表在住院癌症患者焦虑抑郁筛查中临界值的研究［J］.护理学报，2012，19（10A）：1-4. ZHANG W，WANG W L，HONG J F，et al.Research on critical value of hospital anxiety and depression scale in screening anxiety and depression of hospitalized cancer patients［J］.Journal of Nursing，2012，19（10A）：1-4. ［12］DEVLEN J，BEUSTERIEN K，YEN L，et al.The burden of inflammatory bowel disease：a patient-reported qualitative analysis and development of a conceptual model［J］.Inflamm Bowel Dis，2014，20（3）：545-552. ［13］朱迎，丁霞芬，林征，等.炎症性肠病患者生活质量及影响因素调查［J］.护理管理杂志，2013，13（4）：240-241. ZHU Y，DING X F，LIN Z，et al.Investigation of the status and influencing factors of quality of life in patients with inflammatory bowel disease［J］.Journal of Nursing Administration，2013，13（4）：240-241. ［14］朱叶卉，胡雁，吴密彬，等.电话随访对乳腺癌患者服药依从性和生活质量的影响［J］.中华护理杂志，2015，50（1）：69-72. ZHU Y H，HU Y，WU M B，et al.Effect of nurse-led follow-up on medication adherence and quality of life of patients with breast cancer［J］.Chinese Journal of Nursing，2015，50（1）：69-72. ［15］刘庚，李庆印，刘华平.对慢性心力衰竭患者实施标准电话访问管理的效果研究［J］.中华护理杂志，2010，45（3）：201-203. LIU G，LI Q Y，LIU H P.The efficacy of telephone visit in patients with chronic heart failure［J］.Chinese Journal of Nursing，2010，45（3）：201-203. ［16］BAGER P，HENTZE R，NAIRN C.Outpatients with inflammatory bowel disease（IBD）strongly prefer annual telephone calls from an IBD nurse instead of outpatient visits［J］.Gastroenterol Nurs，2013，36（2）：92-96. ［17］VAN MIERLO T，FOURNIER R，FEDORAK R.Don’t forget the doctor：gastroenterologists’ preferences on the development of mHealth Tools for Inflammatory Bowel Disease［J］.JMIR Mhealth Uhealth，2015，3（1）：e5.

[1]	CHEN Chuping, LIU Lidi, YANG Ziyu, ZHANG Peng, ZHANG Rui, YUAN Bo, SHEN Can, YANG Rong, LI Dongze, LIAO Xiaoyang, LEI Yi. Implications for the Management of Chronic Obstructive Pulmonary Disease Patients Based on the Italian Consensus in 2024: Triple Inhalation Therapy in Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2026, 29(06): 688-692.
[2]	CHEN Min, PENG Xiangting, LI Xiaomei, GUAN Wenli, LI Qin, GUO Fuli, YE Rong, ZHAO Caiping. Constructing and Exploring the Practice of Grassroots Community Pharmacy Studios [J]. Chinese General Practice, 2026, 29(05): 568-573.
[3]	LONG Yutong, LU Shiyu, TAN Jie, YANG Bolu, DUAN Jingying, YANG Tongde, YAN Lijing, GONG Enying, SHAO Ruitai. Long-term Medication Adherence Attitudes and Behaviors of Stroke Patients in Rural Areas of China and Related Factors: Based on Follow-up Data from a Certain County in Hebei Province [J]. Chinese General Practice, 2026, 29(02): 170-179.
[4]	REN Panpan, JIA Changli, JIA Jingjing, XU Jinglin, CHEN Mengyao, ZHANG Xiang. The Impact of Livelihood Capitals on the Quality of Life of Rural Older Adults: a Study Based on Different Chronic Disease Conditions [J]. Chinese General Practice, 2026, 29(01): 129-136.
[5]	JIANG Rui, CHANG Guangming, XU Lingling, ZHOU Yuhan, WEI Xinrui, YANG Min, YUE Lu, HUANG Lyuzhuang, WANG Yongchen. Intervention Strategies for Optimizing Chronic Disease Management in Primary Healthcare Services in China: a Perspective Based on Antifragility Development Theory [J]. Chinese General Practice, 2026, 29(01): 17-23.
[6]	CHEN Li, XIONG Weihong, LU Xiaoqin. Study on Medication Compliance and Influencing Factors in Patients after Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(36): 4586-4591.
[7]	LIU Ruihong, CHEN Kai, LI Zhuo, SUN Zuoya, CHEN Zhiyuan. Diagnostic Strategies for Medically Unexplained Symptoms [J]. Chinese General Practice, 2025, 28(35): 4397-4402.
[8]	WANG Lizhu, LI Sihan, WANG Xinyi, MAO Sunxi, QIU Yang, WANG Zhonghua. Pathway Analysis of the Impact of Diabetes Knowledge and Self-efficacy on Self-management and Quality of Survival among Rural Patients with Type 2 Diabetes Mellitus Based on ITHBC Modeling [J]. Chinese General Practice, 2025, 28(34): 4351-4358.
[9]	YAN Xinfeng, YU Chuanning, CAO Sijing, YIN Daogen, SHAN Xiaotao, WANG Yijing, XIE Pei, ZHAO Jie, YANG Weiyi, LIU Gang, HAN Xinxin. Digitally Enabled Generalist-Specialist Collaborative Care on Chronic Care Management of Community under the National Basic Public Health Service: Practical Exploration and Early Achievement [J]. Chinese General Practice, 2025, 28(31): 3897-3903.
[10]	General Practice Branch of Cross-Straits Medicine Exchange Association, General Practice Branch of Zhejiang Medical Association, General Undifferentiated Disease Professional Committee of Zhejiang Society of Mathematical Medicine, the Expert Collaboration Group on Medically Unspecified Disease in General Practice, Chinese Geriatrics Society. Expert Consensus on the Diagnosis, Treatment, and Management of Edema (2025) [J]. Chinese General Practice, 2025, 28(31): 3861-3878.
[11]	HAN Xiao, LI Qiyu, GE Pu, FAN Siyuan, LIU Diyue, WU Yibo, ZHANG Qingshuang. The Impact of Behavioral Lifestyle on Quality of Life in Hypertensive Patients [J]. Chinese General Practice, 2025, 28(26): 3248-3258.
[12]	YAN Fanghong, PENG Guotian, ZHANG Guoli, SUN Ruiyi, MA Yuxia, HAN Lin. Matching Analysis of the Content of Chronic Disease Management for the Elderly in Medical Union: Based on the Perspective of "Guidance-Practice-Need" [J]. Chinese General Practice, 2025, 28(25): 3119-3126,3136.
[13]	WU Yue, WANG Xuetong, KE Bilian. Evaluation of Vision-related Quality of Life in Myopic Macular Degeneration Patients with Low Vision and Associated Factors [J]. Chinese General Practice, 2025, 28(23): 2908-2914.
[14]	BAI Xue, CHEN Qianqian, LI Jie. Innovative Practices in Chronic Disease Management: a New Model for Generalist-Specialist Combination Management of Diabetes and Metabolic Dysfunction-associated Fatty Liver Disease [J]. Chinese General Practice, 2025, 28(23): 2841-2845.
[15]	CHEN Linfeng, WANG Chenxia, HE Jinpeng. Impact of Regular Outpatient Follow-up and Off-site App Engagement on Metabolic Indicators in Type 2 Diabetes Mellitus Patients under the Shared Care Model [J]. Chinese General Practice, 2025, 28(22): 2762-2768.